STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 Celltrion's adalimumab-aaty was previously added to the Costco Member Prescription Program in August 2024 JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ -- Celltrion, Inc....
Read More Details
Finally We wish PressBee provided you with enough information of ( Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program )
Also on site :